Taiwan Liposome Company, Ltd. announced that it has appointed Mr. Horng-Dar Lin was elected as a member of the Board of Directors of the company at the First Extraordinary General Meeting of 2020. Mr. Lin was also appointed to serve on the Audit Committee and Compensation Committee of the Board.Mr. Lin has more than 10 years of industry experience and leadership. Mr. Lin has been the Chairman of Tanvex BioPharma Inc. since December 2018, Chairman of AP Biosciences Inc. since January 2019 and President of Cho Pharma Inc. since August 2019. Previously, Mr. Lin was a Partner of Winston & Strawn LLP, an international law firm, from March 2014 to March 2017.